Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

ICAD - ICAD INC

IEX Last Trade
1.885
-0.005   -0.265%

Share volume: 500
Last Updated: Fri 27 Dec 2024 05:29:22 PM CET
Data Processing, Hosting, and Related Services: 14.30%

PREVIOUS CLOSE
CHG
CHG%
$1.89
0.00
-0.26%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
5%
Profitability 0%
Dept financing 21%
Liquidity 31%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.64%
1 Month
2.89%
3 Months
10.22%
6 Months
39.06%
1 Year
-3.78%
2 Year
0   0%
Key data
Stock price
$1.88
P/E Ratio 
-18.74
DAY RANGE
$1.89 - $1.89
EPS 
-$0.09
52 WEEK RANGE
$1.23 - $2.65
52 WEEK CHANGE
$2.89
MARKET CAP 
42.729 M
YIELD 
N/A
SHARES OUTSTANDING 
26.540 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/13/2024
BETA 
1.15
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$215,470
AVERAGE 30 VOLUME 
$339,955
Company detail
CEO: Stacey M. Stevens
Region: US
Website: icadmed.com
Employees: 140
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Data Processing, Hosting, and Related Services
Sector: Information

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company sells its products through direct sales organizations, as well as through various original equipment manufacturer partners, distributors, technology platform partners, and resellers.

Recent news